The inevitable rise of biosimilars

In the latest in our series based on 2017 UTS Pharmacy Barometer results, John Montgomery looks at how pharmacists view the riding tide of biosimilar medicines  There's little doubt biosimilar medicines will have a profound impact on Australia's pharmaceutical scene. Now available in more than 60 countries, biosimilars provide an alternative to biological medicines and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 7 June 2018
Next Script issues